Ceragenix Pharmaceuticals Report issue

For profit Phase 4
Founded: Denver CO United States (2002)
Status: Defunct (2017)

Organization Overview

First Clinical Trial
2006
NCT00616538
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2007

Timeline

NOW
  • Now

Active Ingredients

Drugs in Phase 4 Trials (3)

epiceram (2 trials)

fluticasone (cutivate) (1 trial)

pimecrolimus (elidel) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Dermatitis (Phase 4)

Dermatitis, Atopic (Phase 4)

Eczema (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 2
  • # of Trial APIs: 3